greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2017

Sanofi (SNY) annual results, year to 31 December 2017: revenue EUR 35,072 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2017 it reported revenue from the sale of goods of EUR 35,072 million ($39.6 billion at the year's average rate), up 3.7% on the year before. Its profit attributable to shareholders was EUR 8,416 million, up 78.7%, and diluted earnings per share EUR 6.64.

Revenue
EUR 35,072 million
+3.7% on the year
FY2015FY2017
Operating margin
16.5%
19.3% a year earlier
FY2015FY2017
Net income
EUR 8,416 million
+78.7% on the year
FY2015FY2017
Diluted EPS
EUR 6.64
+82.9% on the year
FY2015FY2017

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2016Dec 2017 †
Revenue from the sale of goods33,80935,072
Cost of sales10,70111,613
Gross profit23,99524,608
Research and development5,1725,472
Selling, general and administrative9,47810,072
Operating profit6,5315,804
Finance costs924420
Income tax1,3251,722
Profit for the year4,8008,537
Profit attributable to shareholders4,7098,416
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2016Dec 2017 †
Diluted EPS3.636.64
Basic EPS3.666.70
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2016Dec 2017 †
Cash from operations7,8387,379
Cash from investing-2,511-2,896
Cash from financing-4,101-7,902
Buybacks2,9082,162
Dividends paid3,7593,710
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2016Dec 2017 †
Funded by
Equity attributable to shareholders57,55258,070
Non-controlling interests170169
Borrowings, as filed18,50915,468
Other liabilities28,44826,106
Total equity and liabilities104,67999,813
Owned
Property, plant and equipment10,0199,579
Goodwill40,28740,264
Other intangible assets10,87913,080
Cash and cash equivalents10,27310,315
Inventories6,8966,818
Other assets26,32519,757
Total assets104,67999,813
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2016Dec 2017 †
Return on year-end equity8.2%14.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2017, filed 5 March 2020: the filing. The figures are in euros as filed.